HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

agalsidase beta

recombinant protein for treatment of FABRY DISEASE
Also Known As:
Fabrazyme
Networked: 114 relevant articles (18 outcomes, 29 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Germain, Dominique P: 12 articles (12/2020 - 03/2007)
2. Warnock, David G: 10 articles (01/2016 - 01/2007)
3. Wanner, Christoph: 8 articles (01/2021 - 09/2003)
4. Ortiz, Alberto: 7 articles (04/2021 - 03/2012)
5. Wilcox, William R: 7 articles (12/2020 - 01/2007)
6. Linthorst, Gabor E: 7 articles (05/2015 - 07/2007)
7. Pisani, A: 7 articles (01/2013 - 03/2003)
8. Desnick, Robert J: 6 articles (04/2021 - 08/2005)
9. Feldt-Rasmussen, Ulla: 6 articles (12/2020 - 11/2010)
10. Waldek, Stephen: 6 articles (01/2016 - 01/2007)

Related Diseases

1. Fabry Disease (Fabry's Disease)
2. Abdominal Pain (Pain, Abdominal)
3. Diarrhea
4. Inborn Genetic Diseases (Disease, Hereditary)
5. Lysosomal Storage Diseases (Lysosomal Storage Disease)

Related Drugs and Biologics

1. alpha-Galactosidase (Beano)
2. agalsidase beta
3. Enzymes
4. agalsidase alfa
5. globotriaosylceramide (globotriosylceramide)
6. Immunoglobulin G (IgG)
7. Glucosidases
8. Acids
9. Lysergic Acid Diethylamide (LSD)
10. imiglucerase

Related Therapies and Procedures

1. Enzyme Replacement Therapy
2. Therapeutics
3. Aftercare (After-Treatment)
4. Duration of Therapy
5. Intravenous Infusions